Trial Profile
Randomised, Double-Blind, Placebo-Controlled, Parallel Group Trial to Confirm the Efficacy, Safety and Tolerability of Ginkgo biloba Special Extract EGb 761 in Patients Suffering from Mild Mental Impairment (MMI).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2011
Price :
$35
*
At a glance
- Drugs EGb 761 (Primary)
- Indications Mental disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Dr. Willmar Schwabe Pharmaceuticals
- 12 May 2011 New trial record